Annual Report 2020
Division of Cancer Statistics Integration
Kota Katanoda, Megumi Hori, Eiko Saito, Leung Chi Yan, Huang Hsi-Lan, Sayaka Ikeda, Matthew Robert Palmer, Hiroko Takamatsu, Rie Daiten
Introduction
The Division of Cancer Statistics Integration, newly established in FY2017, develops and analyzes comprehensive cancer statistics information including cancer registry data to contribute to the development and evaluation of evidence-based cancer control.
The Team and What We Do
1. Analysis of cancer statistics information
Cancer statistics, including cancer registry data, needs to be scientifically analyzed to serve as a correct, useful, and interpretable source of information. The Division of Cancer Statistics Integration is responsible for analyzing and developing cancer statistics information including cancer registry data to address a variety of needs of public health, clinical, and basic sciences. The cancer statistics we provide are widely used by researchers, policy makers, mass media, health-care providers, patients and citizens.
2. Integration of cancer statistics to develop and evaluate evidence-based cancer control policies
Cancer control policies need to be developed and evaluated based on scientific evidence. For this purpose, the Division of Cancer Statistics Integration combines cancer statistics information with a variety of information regarding prevention, early detection, diagnosis, treatment, palliative care, and health economics, and mathematically analyzes the effects of cancer control policies.
Research activities
1. Cancer statistics website, "Cancer Information Service"
Cancer statistics data and graphical information such as cancer incidence, mortality, and survival are provided on the website "Cancer Information Service", managed by the Center for Cancer Control and Information Services. Our analysis using cancer statistics information is published as a scientific publication in the Japanese Journal of Clinical Oncology (JJCO) and other academic journals. For the general public, the booklet "Cancer Statistics" is also annually published. This fiscal year, we provided cancer mortality data for 2019 and cancer incidence data for 2017, and published the booklet "Cancer statistics in Japan 2021".
2. Research on cancer statistics and cancer control
Cancer statistics information is analyzed and combined with information on cancer prevention, early detection, diagnosis, treatment, palliative care, and health economics to develop and evaluate cancer control policies. This fiscal year, the stage-specific prostate cancer incidence trends were analyzed using a multiple imputation technique; the optimization of endoscopic gastric cancer screening was performed using micro-simulation modelling; and the population-based lung cancer risk was estimated according to smoking status.
3. Others
Our research activities also cover a variety of analysis on cancer and life-style related diseases prevention, early detection, treatment, etc. In this fiscal year, the risk of heated tobacco products was comprehensively examined and filed in a report.
Education
Graduate students were openly recruited in our division under the framework of a joint graduate school in the field of Cancer Statistics and Informatics in collaboration with Osaka University Graduate School of Medicine.
Future Prospects
Based on the development and analysis of cancer statistics information, we aim to realize effective and efficient cancer control measures through the cancer control continuum from prevention to treatment and palliative care.
List of papers published in 2020
Journal
1. Shirabe R, Saito E, Sawada N, Ishihara J, Takachi R, Abe SK, Shimazu T, Yamaji T, Goto A, Iwasaki M, Inoue M, Tsugane S. Fermented and nonfermented soy foods and the risk of breast cancer in a Japanese population-based cohort study. Cancer Med, 10:757-771, 2021
2. Zha L, Liu R, Sobue T, Kitamura T, Ishihara J, Kotemori A, Ikeda S, Sawada N, Iwasaki M, Tsugane S, For The Jphc Study Group. Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study. Nutrients, 13:2021
3. Saito E, Inoue M, Sawada N, Kokubo Y, Yamagishi K, Iso H, Shimazu T, Yamaji T, Iwasaki M, Tsugane S. Risk of stroke in cancer survivors using a propensity score-matched cohort analysis. Sci Rep, 11:5599, 2021
4. Ikeda S, Sobue T, Kitamura T, Ishihara J, Kotemori A, Zha L, Liu R, Sawada N, Iwasaki M, Tsugane S, On Behalf Of The Jphc Study Group. Dietary Acrylamide Intake and the Risks of Renal Cell, Prostate, and Bladder Cancers: A Japan Public Health Center-Based Prospective Study. Nutrients, 13:2021
5. Yang JJ, Yu D, Shu XO, Freedman ND, Wen W, Rahman S, Abe SK, Saito E, Gupta PC, He J, Tsugane S, Gao YT, Xiang YB, Yuan JM, Tomata Y, Tsuji I, Sugawara Y, Matsuo K, Ahn YO, Park SK, Chen Y, Pan WH, Pednekar M, Gu D, Sawada N, Cai H, Li HL, Koh WP, Wang R, Zhang S, Kanemura S, Ito H, Shin MH, Wu PE, Yoo KY, Ahsan H, Chia KS, Boffetta P, Inoue M, Kang D, Potter JD, Zheng W. Quantifying the association of low-intensity and late initiation of tobacco smoking with total and cause-specific mortality in Asia. Tob Control, 30:328-335, 2021
6. Katanoda K, Hori M, Saito E, Shibata A, Ito Y, Minami T, Ikeda S, Suzuki T, Matsuda T. Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018 - a sign of decrease in cancer incidence. J Epidemiol, 2021
7. Acuti Martellucci C, Nomura S, Yoneoka D, Ueda P, Brotherton J, Canfell K, Palmer M, Manzoli L, Giorgi Rossi P, De Togni A, Palmonari C, Califano A, Saito E, Hashizume M, Shibuya K. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study. BJOG, 128:532-539, 2021
8. Hori M, Tanaka H, Saito E, Wakai K, Katanoda K. Response to the Dr Shikata's letter: 'Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies'. Jpn J Clin Oncol, 51:661, 2021
9. Ikeda S, Ueda Y, Hara M, Yagi A, Kitamura T, Kitamura Y, Konishi H, Kakizoe T, Sekine M, Enomoto T, Sobue T. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study. Cancer Sci, 112:839-846, 2021
10. Lau YK, Okawa S, Meza R, Katanoda K, Tabuchi T. Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tob Control, 2021
11. Saito E, Niino M. Age-specific incidence rates of gallbladder cancer in the world. Jpn J Clin Oncol, 51:312-313, 2021
12. Hori M, Palmer M. Age-specific prostate cancer incidence rate in the world. Jpn J Clin Oncol, 51:164-165, 2021
13. Zha L, Sobue T, Kitamura T, Kitamura Y, Ishihara J, Kotemori A, Liu R, Ikeda S, Sawada N, Iwasaki M, Tsugane S, Jphc Study Group FT. Dietary Acrylamide Intake and the Risk of Liver Cancer: The Japan Public Health Center-Based Prospective Study. Nutrients, 12:2020
14. Liu R, Zha L, Sobue T, Kitamura T, Ishihara J, Kotemori A, Ikeda S, Sawada N, Iwasaki M, Tsugane S. Dietary Acrylamide Intake and Risk of Lung Cancer: The Japan Public Health Center Based Prospective Study. Nutrients, 12:2020
15. Saito E, Goto A, Kanehara R, Ohashi K, Noda M, Matsuda T, Katanoda K. Prevalence of diabetes in Japanese patients with cancer. J Diabetes Investig, 11:1159-1162, 2020
16. Saito E, Tang X, Abe SK, Sawada N, Ishihara J, Takachi R, Iso H, Shimazu T, Yamaji T, Iwasaki M, Inoue M, Tsugane S. Association between meat intake and mortality due to all-cause and major causes of death in a Japanese population. PLoS One, 15:e0244007, 2020
17. Zhu J, Smith-Warner SA, Yu D, Zhang X, Blot WJ, Xiang YB, Sinha R, Park Y, Tsugane S, White E, Koh WP, Park SK, Sawada N, Kanemura S, Sugawara Y, Tsuji I, Robien K, Tomata Y, Yoo KY, Kim J, Yuan JM, Gao YT, Rothman N, Lazovich D, Abe SK, Rahman MS, Loftfield E, Takata Y, Li X, Lee JE, Saito E, Freedman ND, Inoue M, Lan Q, Willett WC, Zheng W, Shu XO. Associations of coffee and tea consumption with lung cancer risk. Int J Cancer, 2020
18. Hori M, Saito E, Katanoda K, Tsugane S. Estimation of lifetime cumulative mortality risk of lung cancer by smoking status in Japan. Jpn J Clin Oncol, 50:1218-1224, 2020
19. Svensson, T., et al. "The Association Between Habitual Sleep Duration and Mortality According to Sex and Age: The Japan Public Health Center-based Prospective Study." J Epidemiol 31(2): 109-118.
20. Yagi A, Ueda Y, Masuda T, Ikeda S, Miyatake T, Nakagawa S, Hirai K, Nakayama T, Miyagi E, Enomoto T, Kimura T. Japanese Mothers' Intention to HPV Vaccinate Their Daughters: How Has It Changed over Time Because of the Prolonged Suspension of the Governmental Recommendation? Vaccines (Basel), 8:2020
21. Usui Y, Ito H, Koyanagi Y, Shibata A, Matsuda T, Katanoda K, Maeda Y, Matsuo K. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study. Int J Cancer, 147:3102-3109, 2020
22. Saito E, Hori M, Matsuda T, Yoneoka D, Ito Y, Katanoda K. Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014. Cancer Epidemiol Biomarkers Prev, 29:1222-1228, 2020
23. Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Author Correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep, 10:12950, 2020
24. Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, Nomura S, Shibuya K. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med, 18:257, 2020
25. Leung CY, Huang HL, Rahman MM, Nomura S, Krull Abe S, Saito E, Shibuya K. Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates. BMC Cancer, 20:412, 2020
26. Mawditt C, Sasayama K, Katanoda K, Gilmour S. The clustering of health-related behaviours in the adult Japanese population. J Epidemiol, 2020
27. Palmer M, Saito E. Age-specific incidence rates of ovarian cancer worldwide. Jpn J Clin Oncol, 50:1086-1087, 2020
28. Saito E, Hori M. Age-specific cervical cancer incidence rate in the world. Jpn J Clin Oncol, 50:1229-1230, 2020
29. Saito E, Hori M. Corrigendum to: Age specific colorectal cancer incidence rate in the world. Jpn J Clin Oncol, 50:1483, 2020
30. Hori M, Okuyama A. Age-specific incidence rates of stomach cancer in the world. Jpn J Clin Oncol, 50:724-725, 2020
31. Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci, 111:2156-2162, 2020
32. Yagi A, Ueda Y, Nakagawa S, Ikeda S, Tanaka Y, Sekine M, Miyagi E, Enomoto T, Kimura T. Potential for cervical cancer incidence and death resulting from Japan's current policy of prolonged suspension of its governmental recommendation of the HPV vaccine. Sci Rep, 10:15945, 2020
33. Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Japan's Ongoing Crisis on HPV Vaccination. Vaccines (Basel), 8:2020
34. Sekine M, Yamaguchi M, Kudo R, J B Hanley S, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Epidemiologic Profile of Type-Specific Human Papillomavirus Infection after Initiation of HPV Vaccination. Vaccines (Basel), 8:2020